MX372637B - Proceso para la preparación de diosmina - Google Patents
Proceso para la preparación de diosminaInfo
- Publication number
- MX372637B MX372637B MX2017010026A MX2017010026A MX372637B MX 372637 B MX372637 B MX 372637B MX 2017010026 A MX2017010026 A MX 2017010026A MX 2017010026 A MX2017010026 A MX 2017010026A MX 372637 B MX372637 B MX 372637B
- Authority
- MX
- Mexico
- Prior art keywords
- sub
- diosmin
- preparation
- hesperidin
- iodine
- Prior art date
Links
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 4
- GZSOSUNBTXMUFQ-NJGQXECBSA-N 5,7,3'-Trihydroxy-4'-methoxyflavone 7-O-rutinoside Natural products O(C[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](Oc2cc(O)c3C(=O)C=C(c4cc(O)c(OC)cc4)Oc3c2)O1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 GZSOSUNBTXMUFQ-NJGQXECBSA-N 0.000 title abstract 3
- 229960004352 diosmin Drugs 0.000 title abstract 3
- IGBKNLGEMMEWKD-UHFFFAOYSA-N diosmin Natural products COc1ccc(cc1)C2=C(O)C(=O)c3c(O)cc(OC4OC(COC5OC(C)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 IGBKNLGEMMEWKD-UHFFFAOYSA-N 0.000 title abstract 3
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 title abstract 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 2
- 229910052794 bromium Inorganic materials 0.000 abstract 2
- GZSOSUNBTXMUFQ-YFAPSIMESA-N diosmin Chemical compound C1=C(O)C(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 GZSOSUNBTXMUFQ-YFAPSIMESA-N 0.000 abstract 2
- 229910052740 iodine Inorganic materials 0.000 abstract 2
- 239000011630 iodine Substances 0.000 abstract 2
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 abstract 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 abstract 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 abstract 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 abstract 1
- 229940025878 hesperidin Drugs 0.000 abstract 1
- 150000007529 inorganic bases Chemical class 0.000 abstract 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/06—Benzopyran radicals
- C07H17/065—Benzo[b]pyrans
- C07H17/07—Benzo[b]pyran-4-ones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cephalosporin Compounds (AREA)
Abstract
La presente invención se refiere a un proceso para la preparación de diosmina a partir de hesperidina. El proceso implica la oxidación de hesperidina acilada con yodo o bromo en un medio de ácido carboxílico C2-C4 y posterior tratamiento con una base inorgánica para neutralizar parcialmente los medios ácidos. El proceso permite la obtención de diosmina con bajo contenido de yodo o bromo, evitando el uso de disolventes orgánicos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15153537.4A EP3053930A1 (en) | 2015-02-03 | 2015-02-03 | Process for the preparation of diosmin |
| PCT/EP2016/052165 WO2016124585A1 (en) | 2015-02-03 | 2016-02-02 | Process for the preparation of diosmin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2017010026A MX2017010026A (es) | 2017-12-18 |
| MX372637B true MX372637B (es) | 2025-03-05 |
Family
ID=52477555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017010026A MX372637B (es) | 2015-02-03 | 2016-02-02 | Proceso para la preparación de diosmina |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US10287310B2 (es) |
| EP (2) | EP3053930A1 (es) |
| KR (2) | KR102309525B1 (es) |
| CN (1) | CN107108675B (es) |
| AR (1) | AR103583A1 (es) |
| BR (1) | BR112017016430B1 (es) |
| CA (1) | CA2974860A1 (es) |
| EA (1) | EA032402B1 (es) |
| ES (1) | ES2803213T3 (es) |
| HR (1) | HRP20201102T1 (es) |
| HU (1) | HUE049997T2 (es) |
| LT (1) | LT3253772T (es) |
| MA (1) | MA40703B1 (es) |
| MX (1) | MX372637B (es) |
| MY (1) | MY183290A (es) |
| PH (1) | PH12017501244B1 (es) |
| PL (1) | PL3253772T3 (es) |
| PT (1) | PT3253772T (es) |
| RS (1) | RS60494B1 (es) |
| SI (1) | SI3253772T1 (es) |
| TW (1) | TWI715551B (es) |
| UA (1) | UA123046C2 (es) |
| UY (1) | UY36549A (es) |
| WO (1) | WO2016124585A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106967138A (zh) * | 2017-04-19 | 2017-07-21 | 成都百特万合医药科技有限公司 | 基于二甲亚砜体系的地奥司明生产方法 |
| AR122887A1 (es) | 2020-07-09 | 2022-10-12 | Servier Lab | Procedimiento de preparación de la diosmina |
| AR126366A1 (es) | 2021-07-06 | 2023-10-11 | Servier Lab | Procedimiento para la preparación de diosmina y de fracción flavonoica |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH602778A5 (es) | 1975-05-16 | 1978-07-31 | Hommel Ag | |
| ES440427A1 (es) | 1975-08-25 | 1977-03-01 | Espanola Prod Quimicos | Un procedimiento de obtencion de flavonas. |
| DE2740950A1 (de) | 1977-09-10 | 1979-03-22 | Merck Patent Gmbh | Verfahren zur herstellung von flavonen |
| IT1150612B (it) | 1982-03-04 | 1986-12-17 | Prophin Lab Spa | Procedimento per la preparazione del 1',5,7-tridrossi-4'-metossiflavone-7-rutinoside (diosmina) |
| DE3514123C2 (de) | 1985-04-19 | 1994-12-08 | Kabelmetal Ag | Verfahren zur Herstellung von Durchlaufkokillen für Stranggießmaschinen |
| IT1191620B (it) | 1985-05-30 | 1988-03-23 | Edmond Pharma Srl | Procedimento per la preparazione della diosmina |
| GB9717629D0 (en) * | 1997-08-21 | 1997-10-22 | Johnson Matthey Plc | Removal of residual organic solvents |
| FR2782518A1 (fr) | 1998-08-19 | 2000-02-25 | Innokem Sarl | Procede de fabrication industrielle de diosmine a partir de l'hesperidine par reaction avec de l'iode et de la pyridine |
| CN102653549A (zh) * | 2011-12-28 | 2012-09-05 | 长沙富能生物技术有限公司 | 一种符合ep7版质量标准的地奥司明原料药合成方法 |
-
2015
- 2015-02-03 EP EP15153537.4A patent/EP3053930A1/en not_active Withdrawn
-
2016
- 2016-01-19 TW TW105101530A patent/TWI715551B/zh active
- 2016-02-02 KR KR1020207031757A patent/KR102309525B1/ko active Active
- 2016-02-02 MX MX2017010026A patent/MX372637B/es active IP Right Grant
- 2016-02-02 EP EP16702557.6A patent/EP3253772B8/en active Active
- 2016-02-02 CN CN201680006218.5A patent/CN107108675B/zh active Active
- 2016-02-02 PT PT167025576T patent/PT3253772T/pt unknown
- 2016-02-02 SI SI201630841T patent/SI3253772T1/sl unknown
- 2016-02-02 PL PL16702557T patent/PL3253772T3/pl unknown
- 2016-02-02 BR BR112017016430-2A patent/BR112017016430B1/pt active IP Right Grant
- 2016-02-02 AR ARP160100287A patent/AR103583A1/es active IP Right Grant
- 2016-02-02 KR KR1020177020436A patent/KR102216702B1/ko active Active
- 2016-02-02 UA UAA201707326A patent/UA123046C2/uk unknown
- 2016-02-02 WO PCT/EP2016/052165 patent/WO2016124585A1/en active Application Filing
- 2016-02-02 US US15/544,174 patent/US10287310B2/en active Active
- 2016-02-02 HU HUE16702557A patent/HUE049997T2/hu unknown
- 2016-02-02 EA EA201791280A patent/EA032402B1/ru not_active IP Right Cessation
- 2016-02-02 MY MYPI2017702825A patent/MY183290A/en unknown
- 2016-02-02 RS RS20200814A patent/RS60494B1/sr unknown
- 2016-02-02 MA MA40703A patent/MA40703B1/fr unknown
- 2016-02-02 ES ES16702557T patent/ES2803213T3/es active Active
- 2016-02-02 LT LTEP16702557.6T patent/LT3253772T/lt unknown
- 2016-02-02 CA CA2974860A patent/CA2974860A1/en active Pending
- 2016-02-03 UY UY0001036549A patent/UY36549A/es active IP Right Grant
-
2017
- 2017-07-05 PH PH12017501244A patent/PH12017501244B1/en unknown
-
2019
- 2019-04-02 US US16/373,118 patent/US10711025B2/en active Active
-
2020
- 2020-07-14 HR HRP20201102TT patent/HRP20201102T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112015000671A2 (pt) | sistema de biorrefinaria, métodos e composições dos mesmos. | |
| LT3159409T (lt) | Antiprasminė nukleorūgštis, skirta panaudoti diušeno raumenų distrofijos gydymui | |
| HUE057623T2 (hu) | 3-Aril-4-amido-biciklusos[4,5,0]hidroxiaminosavak HDAC gátlókként | |
| CL2015000706A1 (es) | Compuestos derivados biciclicos conteniendo nitrogeno y sus sales; su proceso de obtencion; composicion farmaceutica que los comprende; y su uso para el tratamiento o profilaxis de estados patologicos renales, hepaticos, inflamatorios, del sistema nervioso, enfermedades fibroticas y rechazo agudo y cronico del trasplante de organos. | |
| CY1121110T1 (el) | Αντινοηματικα-ολιγονουκλεοτιδια ως παρεμποδιστες σηματοδοτησης tgf-r | |
| SG11201601363YA (en) | Process for purifying an acid composition comprising 2-formyl-furan-5-carboxylic acid and 2,5-furandicarboxylic acid | |
| HUE045701T2 (hu) | 2-Hidroxi-1-{4-[(4-fenilfenil)karbonil]piperazin-1-il}etán-1-on származékok és rokon vegyületek mint zsírsav szintáz (FASN) inhibitorok, rák kezelésére | |
| FR3001970B1 (fr) | Procede de preparation d'acide 2,5-furane dicarboxylique | |
| LT2985284T (lt) | Dikarboksirūgšties bis-amido dariniai, jų panaudojimas, farmacinė kompozicija jų pagrindu ir dikarboksirūgšties bis-amido darinių gavimo būdai | |
| MX2015012219A (es) | Proceso para preparar acido levulinico. | |
| BR112014026149A2 (pt) | método para a preparação de 2,4-ácido dihidroxibutírico (2,4-dhb) e microrganismo. | |
| BR112017004925A2 (pt) | composição e método | |
| LT3219316T (lt) | Riebalų rūgščių mišinys (r.r.g., riebalų rūgščių grupė), skirtas naudoti uždegiminių patologijų gydymui | |
| MX372637B (es) | Proceso para la preparación de diosmina | |
| EP3487847A4 (en) | FURANE-2,5-DICARBOXYLIC ACID PURGE PROCESS | |
| CL2017001383A1 (es) | Proceso para la fabricación de anhídrido carboxílico | |
| MX381990B (es) | Proceso para la preparación de sílices precipitadas, sílices precipitadas y sus usos, en particular para el refuerzo de polímeros. | |
| FR3018075B1 (fr) | Procede de preparation de derives d'acide 2,4-diamino-3-hydroxybutyrique | |
| CL2018001490A1 (es) | Sistema y metodo para mitigar incrustaciones durante el proceso de refinamiento de hidrocarburo. | |
| RU2013114011A (ru) | Способ получения олигомера гидрохинона | |
| WO2014193696A3 (en) | Benzimidazole carboxylic acid derivatives, compositions, and methods of use as aurora kinase inhibitors | |
| TH166199A (th) | วิธีการสำหรับการผลิตอัลดีไฮด์อิ่มตัวจาก 1,2-อัลเคนไดออล | |
| TH12097A3 (th) | องค์ประกอบสำหรับสังเคราะห์อนุภาคนาโนซิลิกาเมโซพอร์ | |
| TH12097C3 (th) | องค์ประกอบสำหรับสังเคราะห์อนุภาคนาโนซิลิกาเมโซพอร์ | |
| TH1701003495A (th) | สารประกอบไตรอะโซโลไพริมิดีนและการใช้สารประกอบนี้ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| PD | Change of proprietorship |
Owner name: HEALTHTECH BIO ACTIVES, S.L.U. |